Table 4.
Variable | β | β/SE | p | Sr2 | R2 | ΔR2 | p of ΔR2 |
---|---|---|---|---|---|---|---|
Step 1 | 0.055 | 0.055 | <0.001 | ||||
cGVHD at time of assessment† | −9.891 | −0.234 | <0.001 | −0.234 | |||
Step 2 | 0.521 | 0.466 | <0.001 | ||||
Current cGVHD | −0.808 | −0.019 | 0.676 | −0.018 | |||
Fatigue | −3.117 | −0.595 | <.001 | −0.489 | |||
Physical Functioning | 0.201 | 0.184 | .001 | 0.145 | |||
Step 3 | 0.598 | 0.077 | <0.001 | ||||
Current cGVHD | 0.038 | 0.002 | 0.983 | 0.001 | |||
Fatigue | −1.675 | −0.320 | <.001 | −0.204 | |||
Physical Functioning | 0.135 | 0.123 | 0.015 | 0.096 | |||
Cancer and Treatment Distress | −7.195 | −0.411 | <.001 | −0.267 | |||
Social Support | 0.076 | 0.037 | 0.378 | 0.034 |
Note. N=270
cGVHD: chronic graft versus host disease